<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1443">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05142371</url>
  </required_header>
  <id_info>
    <org_study_id>21406</org_study_id>
    <secondary_id>NCI-2021-11000</secondary_id>
    <secondary_id>21406</secondary_id>
    <secondary_id>P30CA033572</secondary_id>
    <nct_id>NCT05142371</nct_id>
  </id_info>
  <brief_title>Telehealth Exercise Intervention to Improve Physical Function and Frailty in Multiple Myeloma Survivors</brief_title>
  <official_title>Effects of an 8-Week Telehealth Exercise Intervention to Improve Physical Function and Frailty in Multiple Myeloma Survivors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>City of Hope Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>City of Hope Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This clinical trial examines a telehealth exercise intervention in improving physical&#xD;
      function and frailty in multiple myeloma survivors. The exercise program uses a telehealth&#xD;
      platform (delivered by smart phones, tablets, or computers) to view pre-recorded exercise&#xD;
      videos on coordination, posture, stretching, balance, and resistance/aerobic (cardio)&#xD;
      training. Frailty includes being underweight, slow walking speed, exhaustion, low physical&#xD;
      activity, and weakness. Participating in an exercise program may help improve patient's&#xD;
      physical function and strength.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVE:&#xD;
&#xD;
      I. Determine the effects of an 8-week telehealth exercise intervention on physical function&#xD;
      as assessed by the Short Physical Performance Battery (SPPB) test (Aim 1)&#xD;
&#xD;
      SECONDARY OBJECTIVES:&#xD;
&#xD;
      I. Determine the effects of an 8-week telehealth exercise intervention as assessed using a&#xD;
      5-scale frailty index: body mass index (self-report), tiredness (questionnaire), level of&#xD;
      physical activity (self-report), gait speed (sensors), and muscular strength (hand grip&#xD;
      dynamometer) (Aim 2).&#xD;
&#xD;
      II. Determine the sustainability of the intervention on physical function and frailty at week&#xD;
      17 (Aim 3).&#xD;
&#xD;
      OUTLINE: Patients are randomized to 1 of 2 arms.&#xD;
&#xD;
      ARM A: Patients undergo home-based exercise program 3 times per week for 8 weeks. Patients&#xD;
      complete questionnaires at baseline (before 1 week) and at weeks 9 and 17.&#xD;
&#xD;
      ARM B: Patients complete questionnaires at baseline and at week 9 and 17. Patients continue&#xD;
      maintaining current activities of daily living and do not participate in any exercise&#xD;
      program. Patients may then participate in home-based exercise program 3 times per week for 8&#xD;
      weeks.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">December 15, 2021</start_date>
  <completion_date type="Anticipated">December 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Physical function</measure>
    <time_frame>Up to 8 weeks</time_frame>
    <description>Assessed by the Short Physical Performance Battery (SPPB) test.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Frailty index</measure>
    <time_frame>Up to 8 weeks</time_frame>
    <description>Assessed using a 5-scale frailty index: body mass index (self-report), tiredness (questionnaire), level of physical activity (self-report), gait speed (sensors), and muscular strength (hand grip dynamometer).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Plasma Cell Myeloma</condition>
  <arm_group>
    <arm_group_label>Arm A (home-based exercise program)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients undergo home-based exercise program 3 times per week for 8 weeks. Patients complete questionnaires at baseline (before 1 week) and at weeks 9 and 17.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm B (current activities)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients complete questionnaires at baseline and at week 9 and 17. Patients continue maintaining current activities of daily living and do not participate in any exercise program. Patients may then participate in home-based exercise program 3 times per week for 8 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Best Practice</intervention_name>
    <description>Continue current activities of daily living</description>
    <arm_group_label>Arm B (current activities)</arm_group_label>
    <other_name>standard of care</other_name>
    <other_name>standard therapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise Intervention</intervention_name>
    <description>Participate in exercise intervention</description>
    <arm_group_label>Arm A (home-based exercise program)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Quality-of-Life Assessment</intervention_name>
    <description>Ancillary studies</description>
    <arm_group_label>Arm A (home-based exercise program)</arm_group_label>
    <arm_group_label>Arm B (current activities)</arm_group_label>
    <other_name>Quality of Life Assessment</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire Administration</intervention_name>
    <description>Complete questionnaires</description>
    <arm_group_label>Arm A (home-based exercise program)</arm_group_label>
    <arm_group_label>Arm B (current activities)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosed with multiple myeloma&#xD;
&#xD;
          -  &gt;= 18 years old&#xD;
&#xD;
          -  Self-reported as pre-frail or frail (i.e. Fried Criteria: clinically underweight and&#xD;
             exhibiting exhaustion, low energy expenditure, slow walking speed, and muscle&#xD;
             weakness), with the presence of 2/5 indices classified as pre-frail and &gt;= 3/5 indices&#xD;
             classified as frail&#xD;
&#xD;
          -  Has undergone autologous stem cell transplant (ASCT) within 30 and 180 days prior to&#xD;
             registration&#xD;
&#xD;
          -  Physically able and willing to complete all study procedures&#xD;
&#xD;
          -  English-speaking&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Have clinically significant/active cardiovascular disease (e.g. unstable angina,&#xD;
             uncontrolled arrhythmia, etc.)&#xD;
&#xD;
          -  Have contraindications to exercise (acute infectious disease or unstable bone lesions)&#xD;
&#xD;
          -  Currently recovering from a recent injury or have been physically injured in the past&#xD;
             6 months, in which participation in rigorous exercise may not be appropriate&#xD;
&#xD;
          -  Participate in regular, structured exercise (&gt; 60 minutes/week)&#xD;
&#xD;
          -  Female patients who are pregnant or planning to become pregnant&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kyuwan Lee</last_name>
    <role>Principal Investigator</role>
    <affiliation>City of Hope Comprehensive Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>City of Hope Comprehensive Cancer Center</name>
      <address>
        <city>Duarte</city>
        <state>California</state>
        <zip>91010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kyuwan Lee</last_name>
      <phone>626-218-6497</phone>
      <email>kylee@coh.org</email>
    </contact>
    <investigator>
      <last_name>Kyuwan Lee</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 29, 2021</study_first_submitted>
  <study_first_submitted_qc>November 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 2, 2021</study_first_posted>
  <last_update_submitted>November 19, 2021</last_update_submitted>
  <last_update_submitted_qc>November 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Myeloma</mesh_term>
    <mesh_term>Neoplasms, Plasma Cell</mesh_term>
    <mesh_term>Frailty</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

